What is it about?
Directly delivering drugs along nerve cells offers a promising way to treat neurological diseases and manage chronic pain while bypassing the blood–brain barrier and avoiding the harmful side effects of systemic drug delivery. In this paper, we developed a mathematical model to study how specialized drug packages—called pharmaceutical agent complexes (PACs)—travel along nerve fibers (axons) toward the cell body. These drug packages rely on molecular motors (dynein) that pull them along cellular tracks, but as they move, some packages get temporarily trapped and rereleased at specialized sites called Nodes of Ranvier. Our model builds on recent experimental findings by incorporating both motor-driven transport and microscopic diffusion, which accounts for Brownian motion and the randomness of motor unbinding. We used a hybrid mathematical approach combining Laplace transforms and numerical inversion to solve the transport equations. This allowed us to simulate how drug concentrations spread, move, and accumulate along the axon over time under various kinetic and physical conditions.
Featured Image
Photo by Jacob Stephens on Unsplash
Why is it important?
Understanding the physical mechanisms governing targeted drug transport inside neurons is essential for designing effective "smart drugs" that harness the cell's internal transport machinery. While recent experimental work demonstrated that tripartite drug complexes can achieve a 300-fold reduction in required dosage and a 10-fold increase in drug half-life compared to systemic administration, mathematical models were needed to clarify how transport parameters dictate delivery speed and spread. Our work fills this critical gap by providing a mathematically tractable framework that incorporates both temporary structural trapping and random diffusion. Two key insights emerge from our modeling: first, diffusion causes drug pulses to smooth out and spread as they travel, whereas transport speed is governed entirely by how frequently drug packages exchange with stationary cellular sites. When exchange with stationary sites is rapid, drug packages spend roughly half their time paused, cutting their overall delivery speed in half compared to molecular motor speeds. These findings provide valuable quantitative guidance for bioengineers designing next-generation targeted drug delivery systems to optimize transport into the central nervous system.
Perspectives
Developing this model was a particularly satisfying challenge because it bridges theoretical transport phenomena with exciting clinical applications in targeted drug delivery. It was deeply rewarding to translate complex cellular interactions—such as dynein motor motion, molecular diffusion, and temporary binding at Nodes of Ranvier—into clean mathematical equations that can be solved with elegant Laplace transform techniques. Seeing our mathematical predictions align so well with experimental observations from biomedical literature reinforced the power of applied mechanics in solving biological problems. I hope this work demonstrates to both engineers and biomedical researchers how mathematical modeling can unlock a deeper, quantitative understanding of intracellular processes. As nanomedicine advances, tools like this model will become increasingly vital for designing targeted therapies that treat neurological disorders more effectively and with fewer side effects. Ultimately, I hope this research inspires further interdisciplinary collaboration between mechanical engineering, mathematics, and neuroscience.
Andrey V Kuznetsov
North Carolina State University
Read the Original
This page is a summary of: A model of axonal transport drug delivery: effects of diffusivity, International Journal for Numerical Methods in Biomedical Engineering, February 2012, Wiley,
DOI: 10.1002/cnm.2469.
You can read the full text:
Contributors
The following have contributed to this page
